IDHC
vs
S&P 500
IDHC
S&P 500
Over the past 12 months, IDHC has significantly outperformed S&P 500, delivering a return of +40% compared to the S&P 500's +13% growth.
Stocks Performance
IDHC vs S&P 500
Performance Gap
IDHC vs S&P 500
Performance By Year
IDHC vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Integrated Diagnostics Holdings PLC
Glance View
Integrated Diagnostics Holdings Plc engages in the provision of diagnostics services including pathology and molecular diagnostics, genetics testing and basic radiology to patients and other laboratories. The firm operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology and radiology. Its brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Echo-Lab (Nigeria). The company operates in approximately 507 branches. IDH offers 2,000 diagnostic pathology tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy, and substance abuse. Through Al Borg Scan, it offers a range of radiology services, including but not limited to magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, x-ray, mammograms, cath lab facilities, and positron emission tomography-computed tomography (PET-CT).
